Theratechnologies Announces Agreement in Principle with Mara

- Removal of Minimum Liquidity Covenant of US$30 Million if F8 Formulation of Tesamorelin is Not Approved by the FDA by March 31, 2024- Minimum Li...

Related Keywords

Montreal , Quebec , Canada , United States , Toronto , Ontario , Philippe Dubuc , Julie Schneiderman , Toronto Stock Exchange , Company Auditors , Communications Corporate Affairs , Drug Administration , Theratechnologies Inc , Minimum Liquidity Covenant , Not Approved , Liquidity Covenant , Decrease Over Time , Targeted Adjusted , Going Concern Note , Annual Report , Marathon Asset Management , Loan Facility , United States Food , Forward Looking Statements , Looking Statements , Annual Information Form , Vice President , Chief Financial Officer ,